• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 20
  • 10
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 5
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 49
  • 49
  • 20
  • 16
  • 14
  • 14
  • 14
  • 14
  • 9
  • 6
  • 6
  • 5
  • 5
  • 4
  • 4
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Amniotic fluid fatty acids and cholesterol and their association with pregnancy outcomes

Enros, Erin. January 2006 (has links)
The objectives were (1) to establish a profile of total fatty acids and cholesterol in amniotic fluid (AF) as well as (2) to determine possible associations between AT fatty acids (micromolar and relative proportion) with gestational age and birth weight. A total of 208 AF samples collected between 12 and 22 weeks of gestation during routine amniocentesis were analyzed using tandem column gas chromatography (GC). Smoking increased AF polyunsaturated fatty acid (PUFAs) levels while developmental stage and storage time decreased AF fatty acid quantities. AF trans fatty acids (TFAs) were negatively associated with both birth outcomes, whereas specific fatty acids including stearic acid (C18:0) and gondoic acid (C20:1n-9) were identified as negative predictors for gestational age and birth weight respectively. This study demonstrated novel relationships between fatty acids and fetal growth and gestational age in early midgestation AF, suggesting a possible role of AF fatty acids in predicting birth outcomes.
22

Restricted implantation and undernutrition alter development and growth of the ovine placenta.

Chidzanja, Stivelia January 1994 (has links)
Bibliography: 161-199. / [xxvi], 199, [151] leaves, [7] leaves of plates : ill. (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Characterises the normal otogeny of the cellular composition and structure of placentomes in sheep, their relationship to the macroscopic parameters of placentome size and morphology, and the effect of experimental and natural restriction of implantation on the growth and development of placentomes between mid and late gestation. / Thesis (Ph.D.)--University of Adelaide, Dept. of Obstetrics and Gynaecology, 1995
23

Role of IGF-I in ovine fetal and placental growth and development / Fong Lok.

Lok, Fong January 1998 (has links)
Bibliography: p. 190-234. / 276 p. : ill. ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Aims to directly test the hypothesis that restricting placental delivery of oxygen and nutrients to the fetus restricts fetal growth, in part by reducing endogenous production of insulin like growth factor-I / Thesis (Ph.D.)--University of Adelaide, Dept. of Obstetrics and Gynaecology, 1999?
24

The impact of rhizoma chuanxiong in fetal bone development

Xu, Wei 26 May 2016 (has links)
Background and purpose: Rhizoma Chuanxiong (CX), the dry rhizome of Ligusticum chuanxiong Hort., is a commonly used Chinese herbal medicine to treat gynecological diseases. So far, more than 60 chemical components have been identified from CX such as volatile oils (ligustilide, etc.), phenolic acids (ferulic acid, etc.) and alkaloids (chuanxiongzine, etc.). These components in CX are the basis of its wide pharmacodynamic actions including estrogen-like, progesterone-like and anti-coagulant/anti- platelet effects. In our recent survey based on previous published clinical trials, CX was ranked as one of the top 20 herbs commonly used for anti-miscarriages amongst Chinese pregnant women. However, CX should be used with caution during pregnancy as its property of 2invigorating blood circulation and removing blood stagnation3. Despite its wide applications, the safe dosage of CX in pregnant women remains unclear with no records found in the current Chinese Pharmacopoeia or other guidelines. Thus, verification regarding the impacts of CX preparations and its components in embryonic development is urgently required. In view of the limited experimental evidence that is currently available to assess the safety of CX, this project aims to (1) identify the general impacts of CX aqueous extract in maternal function and fetal development with an in vivo mouse model; and to (2) investigate the adverse impacts and underlying mechanisms of CX aqueous extract in fetal bone development with a biomarker assay and metabolomics analysis.;Concusion: CX aqueous extract at a low dosage of 2 g/kg/day (equals to the daily dosage of human adults) did not cause adverse effect in pregnant mice, and it suggested that this dosage of CX preparations should be safe for pregnant women. Our data demonstrated that high dosage and long-term use of CX aqueous extract might result in embryonic toxicities including fetal bone malformations for the first time. As the CX aqueous extract in this study was not contaminated by pesticide residues and heavy metals, the adverse impacts of CX aqueous extract should be considered as a result of its intrinsic components in the herb. Furthermore, CX aqueous extract might significantly down-regulate biomarkers related to bone formation and metabolism during osteogenesis. It is therefore valuable to establish a practical approach to systematically assess the safety of CX and other herbal medicines.;Method: Referred to the guidelines of WHO, the Chinese Pharmacopoeia and the Hong Kong Chinese Materia Medica Standards, CX aqueous extract was prepared, and its reference marker (ligustilide and ferulic acid) were quantitatively authenticated by HPLC analysis. LC/MS fingerprint analysis was performed for the quality control purposes. In addition, pesticide residues and heavy metals found in CX aqueous extract were examined using GC-MS and ICP-MS analysis. In the Segment II study as per FDA and OECD guidelines, pregnant mice were randomly assigned into 6 groups (n=18 per group): i.e. mice were orally administrated with distilled water as the negative controls (Group 1); or CX aqueous extract of 2, 16, 24 and 32 g/kg/day respectively from the gestation day (GD)6 to 16(Group 2, 3, 4 and 5); or vitamin A (200,000 IU) on GD7, 9 and 11 as the positive controls (Group 6). All mice were sacrificed to assess maternal and fetal parameters on the GD18. In the mechanistic study, the expressions of biomarkers related to fetal bone development including PICP, ICTP, B-ALP, BGP, Gdf-5, BMPs, BMP-6, BMP-8, BMP-11, IL-4, IL-4r, IL-10 and IL-10r in fetal tissue samples of the Group 1 and 5 (32 g/kg/day, n=18) were measured using ELISA analyses on GD16. Meanwhile, the metabolites of two-group samples were also analyzed by the UHD Accurate-Mass Q- TOF LC/MS, and profiling data was further analyzed by specific software. During statistical analysis, measurement data from G1, 2, 3 4 and 5 groups were analyzed using one-way ANOVA(SPSS software, version 16.0). LSD test in Post hoc method was applied to compare differences between every two groups. Pearsons x 2 - test was used to analyze category data from G1, 2, 3, 4 and 5 groups, and Fishers exact test was applied to compare differences between different groups. The student t-test was also used to compare differences between G1 and G6 groups in animal studies as well as G1 and G5 groups using ELISA or metabolomics results. An intragroup difference with a p-value less than 0.05 was considered as statistical significant.;Resutt:(1) There was no statistical significant difference in maternal and fetal parameters found between the Group 1 and 2 (p> 0.05). However, the maternal body weight (BW), gravid uterine weight, corrected BW change, live fetus/litter, mean fetal BW in the Group 4 and 5 were significantly lower than those in the Group 1(p
25

Amniotic fluid fatty acids and cholesterol and their association with pregnancy outcomes

Enros, Erin. January 2006 (has links)
No description available.
26

Oxidative and nitrative stress biomarkers in amniotic fluid and their association with fetal growth and pregnancy outcomes

El-Halabi, Dima. January 2007 (has links)
No description available.
27

Early second trimester amniotic fluid erythropoietin and pregnancy outcomes

Di Giovanni, Jessica Louise. January 2008 (has links)
No description available.
28

Pregnancy outcomes of Kansas WIC program participants aged 20 years and older

Cordill, Anita J January 2011 (has links)
Typescript (photocopy). / Digitized by Kansas Correctional Industries
29

Intrinsic and extrinsic influences on final height

Luo, Zhongcheng., 駱忠誠. January 2000 (has links)
published_or_final_version / Paediatrics / Doctoral / Doctor of Philosophy
30

Early embryos of dams of heat stress

Johnsen, Suzanne Louise, 1960- January 1989 (has links)
Increased environmental heat causes early embryonic death before implantation. This study was designed to examine tissues of dams exposed to environmental temperatures of 36°C and to examine 72 hour old embryos from these dams. Results showed adult mice exposed to heat stress had significant changes in liver morphology with hepatocyte swelling and vacuolization of the cytoplasm, organelles in the hepatocytes were displaced next to the cell membrane. After 48 hours of recovery from heat stress, liver morphology appeared normal. Embryos from heat stressed dams had delayed development indicated by increased 2alpha helical cellular inclusions. Embryos responded differently to different fixation techniques indicated permeability changes in either the zona pellucida or cellular membranes. Litter size or pup survivability from heat stressed dams allowed to recover indicated changes seen at this point were reversible

Page generated in 0.0426 seconds